Overview


According to FutureWise analysis the market for double chamber prefilled syringes in 2023 is US$ 2.12 billion, and is expected to reach US$ 4.35 billion by 2031 at a CAGR of 9.40%.

The double chamber prefilled syringes has been a crucial innovation in mitigating the risks related with the erroneous drug dosage. According to the parenteral delivery system, a conventional syringe is at its optimum for over 12 hours while the double chamber syringes are being developed in such a manner that the sterility will be maintained for over 3 years. These syringes are allowed to inject the drug in appropriate depth, and it does not require any supervision from professionals which is why they are widely available through distribution channels that are efficiently streamlined. Such factors shall boost the double chamber prefilled syringes market growth.

  • Pfizer Inc.
  • Credence MedSystems Inc.
  • AstraZeneca Plc.
  • Maeda Industry Co. Ltd.
  • Biosciences, Inc.
  • Ypsomed AG
  • Otsuka America Pharmaceutical, Inc.
  • Vetter Pharma International GmbH
  • AbbVie Inc.
  • Nipro Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • <1.0 ml
  • 1.0 – 2.5 ml
  • 2.5 – 5.0 ml
  • >5 ml

By Material Type

  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes

By Application

  • Liquid/Liquid
  • Liquid/Powder
  • Liquid/Lyophilizate

By Indication

  • Haemophilia
  • Schizophrenia
  • Diabetes
  • Erectile Dysfunction
  • Endometriosis
  • Precocious Puberty

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The market is categorised into product, material type, application, indication, distribution channel and region. The product segment is fragmented into <1.0 ml, 1.0 – 2.5 ml, 2.5 – 5.0 ml, >5 ml. The material type segment is glass prefilled syringes and plastic prefilled syringes. The application segment liquid/liquid, liquid/powder and liquid/lyophilizate. The distribution channel segment is hospital pharmacies, retail pharmacies and online pharmacies.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the global double chamber prefilled syringes market by product, by material type, by application, by indication, by distribution channel and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Double Chamber Prefilled Syringes Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Double Chamber Prefilled Syringes Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Double Chamber Prefilled Syringes Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Double Chamber Prefilled Syringes Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. <1.0 . ml
        2. 1.0 . – 2.5 . ml
        3. 2.5 . – 5.0 . ml
        4. >5 ml

  • 8.   Double Chamber Prefilled Syringes Market, By Material Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Glass Prefilled Syringes
        2. Plastic Prefilled Syringes

  • 9.   Double Chamber Prefilled Syringes Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Liquid/Liquid
        2. Liquid/Powder
        3. Liquid/ Lyophilizate

  • 10.   Double Chamber Prefilled Syringes Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hemophilia
        2. Schizophrenia
        3. Diabetes
        4. Erectile Dysfunction
        5. Endometriosis
        6. Precocious Puberty

  • 11.   Double Chamber Prefilled Syringes Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies

  • 12.   North America Double Chamber Prefilled Syringes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Double Chamber Prefilled Syringes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Double Chamber Prefilled Syringes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Double Chamber Prefilled Syringes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Double Chamber Prefilled Syringes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Pfizer Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Credence MedSystems Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. AstraZeneca Plc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Maeda Industry Co. Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Biosciences, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Ypsomed AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Otsuka America Pharmaceutical, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Vetter Pharma International GmbH
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. AbbVie Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Nipro Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients